EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low-dose biliatresone treatment of pregnant mice causes subclinical biliary disease in their offspring: Evidence for a spectrum of neonatal injury

Kapish Gupta iD, Jimmy P Xu, Tamir Diamond iD, Iris E M de Jong, Andrew Glass, Jessica Llewellyn, Neil D Theise, Orith Waisbourd-Zinman, Jeffrey D Winkler, Edward M Behrens, Clementina Mesaros, Rebecca G Wells iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0301824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Kapish Gupta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylva…. Hauptthemen laut MEDLINE: Biliary Atresia, Gallbladder Diseases, Benzodioxoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIEHS NIH HHS, NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biliary atresia is a neonatal disease characterized by damage, inflammation, and fibrosis of the liver and bile ducts and by abnormal bile metabolism. It likely results from a prenatal environmental exposure that spares the mother and affects the fetus. Our aim was to develop a model of fetal injury by exposing pregnant mice to low-dose biliatresone, a plant toxin implicated in biliary atresia in livestock, and then to determine whether there was a hepatobiliary phenotype in their pups. Pregnant mice were treated orally with 15 mg/kg/d biliatresone for 2 days. Histology of the liver and bile ducts, serum bile acids, and liver immune cells of pups from treated mothers were analyzed at P5 and P21. Pups had no evidence of histological liver or bile duct injury or fibrosis at either timepoint. In addition, growth was normal. However, serum levels of glycocholic acid were elevated at P5, suggesting altered bile metabolism, and the serum bile acid profile became increasingly abnormal through P21, with enhanced glycine conjugation of bile acids. There was also immune cell activation observed in the liver at P21. These results suggest that prenatal exposure to low doses of an environmental toxin can cause subclinical disease including liver inflammation and aberrant bile metabolism even in the absence of histological changes. This finding suggests a wide potential spectrum of disease after fetal biliary injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary AtresiaGallbladder DiseasesBenzodioxolesPregnancyFemaleAnimalsMiceLiverBile DuctsInflammationFibrosisBile Acids and Salts

Substanzen

biliatresoneBile Acids and SaltsBenzodioxoles

Autor:innen und Institutionen

  • Department of Medicine, Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Center for Engineering MechanoBiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Center of Excellence in Environmental Toxicology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
  • Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Department of Pathology, School of Medicine, New York University, New York, New York, United States of America.

ORCID-Profile: Kapish Gupta, Tamir Diamond, Rebecca G Wells

Förderung

  • NIDDK NIH HHS
  • NIEHS NIH HHS
  • NIDDK
  • Children's Hospital of Philadelphia
  • United States-Israel Binational Science Foundation
  • NIEHS

Zitieren

APA

Gupta, K., Xu, J. P., Diamond, T., de Jong, I. E. M., Glass, A., Llewellyn, J., Theise, N. D., Waisbourd-Zinman, O., Winkler, J. D., Behrens, E. M., Mesaros, C., & Wells, R. G. (2024). Low-dose biliatresone treatment of pregnant mice causes subclinical biliary disease in their offspring: Evidence for a spectrum of neonatal injury. PLOS ONE. https://doi.org/10.1371/journal.pone.0301824

Vancouver

Gupta K, Xu JP, Diamond T, de Jong IEM, Glass A, Llewellyn J, et al. Low-dose biliatresone treatment of pregnant mice causes subclinical biliary disease in their offspring: Evidence for a spectrum of neonatal injury. PLOS ONE. 2024. doi:10.1371/journal.pone.0301824

BibTeX
@article{Gupta2024,
  author = {Gupta, Kapish and Xu, Jimmy P and Diamond, Tamir and de Jong, Iris E M and Glass, Andrew and Llewellyn, Jessica and Theise, Neil D and Waisbourd-Zinman, Orith and Winkler, Jeffrey D and Behrens, Edward M and Mesaros, Clementina and Wells, Rebecca G},
  title = {Low-dose biliatresone treatment of pregnant mice causes subclinical biliary disease in their offspring: Evidence for a spectrum of neonatal injury},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0301824}
}
Kostenlos starten →